Tuesday, 22 December 2020

Proactive Investors Interview: BioLargo expects its growing quarterly momentum to continue into 2021

 

BioLargo, Inc. (OTCQB:BLGO) CEO Dennis Calvert tells Proactive the developer of sustainable technologies' current fourth-quarter revenues of approximately $750,000 will result in new quarterly and annual records for the company.

Calvert says he expects this to continue, as the group is seeing market adoption of its products, it will have more assets coming to market, as well as potential partnerships and distribution efforts.

BioLargo Announces Funding for Design/Installation of Full-Scale “Zero Liquid Discharge” Wastewater Treatment and Reuse Project

Alberta Innovates commits to provide significant funding

Westminster, CA – December 22, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of cutting-edge environmental technologies and a full-service engineering company, announced today that its Canadian subsidiary has received grant funding necessary to begin the design and construction of a full-scale farm-wide “zero liquid discharge” wastewater treatment and reuse project at Sunworks Farm, an organic poultry producer in Alberta, Canada.

Scheduled to begin operating next year, BioLargo will design, build, install and operate a custom water treatment train featuring its patented Advanced Oxidation System (AOS) technology. The system will treat all wastewater produced by farming operations and convert it to reusable water, saving the farm money and reducing its environmental impact. This project will make Sunworks Farm the first “zero liquid discharge” poultry facility in Alberta Canada, a significant technical and environmental achievement for both companies and for the Canadian poultry industry.

Alberta Innovates has committed funding for the project through the Water Innovation Program (https://albertainnovates.ca/programs/water-innovation/).

BioLargo Water President Dr. Richard Smith commented, “Poultry production in North America results in the discharge of over 60 billion gallons of wastewater into the environment every year, with few farms currently opting for capture and reuse systems. Zero liquid discharge systems are increasing in popularity due to their water use and discharge cost savings and because of the substantial environmental benefits. Our goal is for the AOS to be a by-word for water reuse.”

“BioLargo’s Advanced Oxidation System (AOS) technology has the potential to protect Alberta’s water quality and improve water reuse at Sunworks Farm. Advancing the reuse of wastewater through innovation is an important way to support economic development and environmental stewardship in Alberta”, says Dr. Brett Purdy, Executive Director of Environmental Innovation at Alberta Innovates.

To learn more about BioLargo Water and the AOS, visit www.biolargowater.com and the website of the parent company BioLargo at www.biolargo.com.

 

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About Alberta Innovates

Alberta Innovates invests in research, innovation and entrepreneurship to drive provincial economic growth and diversity. We ignite the power of innovation through our work with researchers, industry and entrepreneurs to move Alberta to a lower-carbon future, promote the responsible use of land and water, and contribute to the improved health and well-being of Albertans.

Alberta Innovates provides technical expertise, entrepreneurial advice and support, opportunities for partnerships, and funding to advance the best ideas. We support a broad range of research and innovation activity – from discovery to use. Collaboration is at the heart of what we do – bringing together bright minds and great ideas.  

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

During the course of the stockholder presentation, BioLargo may make “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, regarding future events or the future financial performance of the company that are subject to change. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

 

Monday, 21 December 2020

BioLargo to Sponsor Nightingale 2030 Resilience Fund Special Online Theatrical Event – What Would Flo Do?

The event, organized by Nightingale 2030 Resilience Fund, will honor frontline healthcare workers around the world

Westminster, CA – December 21, 2020 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies, full-service environmental engineering firm and parent company to Clyra Medical Technologies, makers of Clyraguard Personal Protection Spray, today announced support for an innovative and timely virtual theatrical event inspired by the life and legacy of the founder of modern nursing, Florence Nightingale, titled What Would Flo Do?. The play is being produced by the Nightingale 2030 Resilience Fund, a non-profit organization that supports nurses and midwives around the world.

“Nurses are heroic, and that statement has never been truer than it is right now,” said Dennis P. Calvert, President and CEO of BioLargo. “Through Clyra Medical Technologies and our Clyraguard Personal Protection Spray, we are working to help frontline healthcare providers do their lifesaving work more safely and effectively, so supporting the Nightingale 2030 Resilience Fund is a natural fit with our mission.”

What Would Flo Do? is a virtual documentary play premiering on Tuesday, December 22 on Zoom, directed by Tony Award winner Tim Kashani. It will take audiences into the world of nurses today and into the world of Florence Nightingale in her later years as a thought-leader, statistician, change agent and founder of the nursing profession. The premiere highlights the Thank-a-Nurse Campaign sponsored by the Nightingale 2030 Resilience Fund. This play is the first in a series with additional showings planned for 2021 and beyond.

To watch What Would Flo Do?, visit https://www.whatwouldflodo.com and click “Join Zoom” at 4:30pm PST on December 22, 2020. Additional information on What Would Flo Do? and the Nightingale 2030 Resilience Fund is available at https://nightingale2030.org

BioLargo’s support of the Nightingale 2030 Resilience Fund includes a donation of Clyraguard to nurses to help keep them safe during the pandemic. Clyraguard is an FDA-registered hospital-grade disinfectant for personal protective equipment (PPE) including face masks that is manufactured by BioLargo’s subsidiary Clyra Medical Technologies.

Clyraguard can be purchased online at https://truepurposebrands.com/, with a percentage of profits from sales to support the Nightingale 2030 Resilience Fund.

2020 is the 200th anniversary of the birth Florence Nightingale, the founder of modern nursing who trained field nurses during the Crimean War. To honor her memory, the World Health Organization has called 2020 the “International Year of the Nurse and Midwife” in support of nurses’ and midwives’ crucial role in advancing healthcare around the world – especially in light of the COVID pandemic.

 

About Nightingale 2030 Resilience Fund

The Nightingale 2030 Resilience Fund is supporting nurses, midwives, and caregivers throughout their lives beginning when licensed or certified in healthcare specialties continuing through retirement. We give nurses the tools and resources to be resilient in their profession, personal lives, and to help out in their communities.

The Nightingale 2030 Resilience Fund is a 501(c)(3) non-profit organization with fiscal sponsorship from Partnerships For Change.

The Nightingale 2030 Resilience Fund is committed to making a difference in the advancement of the United Nations Sustainable Development Goals (SDGs).  Goals that impact the world in which nurses play a vital role: no poverty; no hunger; good health; quality education; gender equality; clean water and sanitation; renewable energy; good jobs & economic growth; innovation & infrastructure; reduced inequalities; sustainable cities & communities; responsible consumption: climate action; life below water; life on land; peace & justice; and partnerships for goals!

About True Purpose Brands

True Purpose Brands is dedicated to curating products that are clean, safe, and sustainably formulated using proprietary science. All of their innovative products are non-toxic and eco-friendly, meaning they are safe for people, pets, plants, and the planet.

Their True Purpose is to instill confidence that their products perform to a New Standard of Safe and Clean.

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard (www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

BioLargo to Report Record Revenues in Fourth Quarter of 2020

Westminster, CA – December 21, 2020 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and a full-service environmental engineering company, today announced that its current fourth quarter revenues of approximately $750,000 will result in new quarterly and annual records for the company.

In addition to setting revenue records, BioLargo also significantly reduced its debt obligations during the year. At December 31, 2019, its balance sheet showed approximately $4.6 million in notes payable and lines of credit, not including solely owed obligations of its partially owned subsidiary Clyra Medical. During this calendar year, BioLargo reduced the $4.6 million owed by over $2.8 million to approximately $1.7 million. Of that amount, $357,000 are SBA Paycheck Protection Act loans (which management expects will be forgiven in accordance with SBA’s terms), $200,000 will be converted to equity at maturity, and the remaining approximately $1.1 million may be converted by the investors and if not, will mature in August 2021.

BioLargo CEO Dennis P. Calvert commented, “I am proud of our team’s accomplishments in 2020, and am optimistic that we can continue the momentum next year and further improve our financial condition with successful execution of projects and contracts already in hand, as well as new product launches. Of course, multiple factors may affect the timing and amount of our sales, including uncertainties and unusual challenges related to the pandemic, and the obvious challenges inherent in introducing new technologies to the market.”

In a presentation recorded at the LD Micro virtual investor conference on December 14, 2020, Mr. Calvert explained that the company needs to reach approximately $1.25 million in quarterly revenues to get to cash-flow positive for operations supported by BioLargo (which excludes Clyra, which is independently financed). In the video, available below, he also explained the drivers behind the record revenues and detailed the company’s plans to launch its long-anticipated water treatment technologies, the BioLargo AOS and BioLargo AEC, in 2021. 

Watch the video here: https://www.biolargo.com/ld-micro-conference-video

See caution regarding forward looking statements, below.


About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

During the course of the stockholder presentation, BioLargo may make “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, regarding future events or the future financial performance of the company that are subject to change. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.


Friday, 18 December 2020

Recent Clyraguard Media Hits

Clyraguard was featured in several articles this week! The product is picking up traction in the media, and it's having a positive effect on our online sales. 

Check out some recent articles:

1. Florida Weekly interview with Clyra President Steve Harrison about Clyraguard. Read here: https://fortmyers.floridaweekly.com/articles/filling-a-need/ 

2. Boy Genius Report covered Clyraguard in a follow-up article.

Wednesday, 16 December 2020

BioLargo 13th Annual LD Micro Main Event Presentation Video


 
On Monday December 14, BioLargo President and CEO Dennis Calvert presented on BioLargo's vision for growth over the coming year, focusing on the convergence of several key commercial launches that are soon to take place with the company's innovative environmental technologies and solutions. 

The company's revenues are increasing and its debt is decreasing, and our water treatment and air quality control solutions are key revenue drivers that will propel the company to positive cash flow and beyond. 

Watch the full video of Dennis' presentation above! If you prefer to simply download the deck, you can do that at this link.

Thank you to LD Micro who organized an excellent investor conference.

Wednesday, 9 December 2020

BioLargo to Present at the 13th Annual LD Micro Main Event Conference

WESTMINSTER, CA – December 9, 2020 / BioLargo (OTCQB:BLGO), developer of environmental technologies and a full-service engineering company, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on Monday, December 14 at 6:00 AM PST / 9:00 AM EST. BioLargo President and CEO Dennis P. Calvert will present to a live, virtual audience.

Mr. Calvert will showcase BioLargo’s portfolio of disruptive technologies in water treatment, air quality control, PFAS remediation, and COVID-19 protection. He will cover the drivers for the company’s recent record revenues and explain why this a pivotal period for the company and its investors. To learn more about BioLargo, visit www.biolargo.com and visit the company’s blog at www.biolargo.blogspot.com.

Register to watch the virtual presentation here: ve.mysequire.com/. Registration is free.

LD Micro’s 13th annual Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts. With over 250 companies scheduled to present, over two million investors invited, and a one-on-one interview with NBA legend, entrepreneur, philanthropist and philosopher Shaquille O’Neal, this year’s program promises something for everyone.

"The time has finally come to do something different in the virtual conference world. Let’s see if we can pull off something that can be enjoyed by both executives and investors alike,” stated Chris Lahiji, Founder of LD Micro, now a wholly owned subsidiary of SRAX, Inc.

The Main Event will take place on December 14th and 15th, exclusively on the Sequire Virtual Events platform.

View BioLargo’s profile here: http://www.ldmicro.com/profile/BLGO

 


Profiles powered by LD Micro

 

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard (www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About LD Micro/SEQUIRE

LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. For more information, please visit ldmicro.com.

The upcoming Main Event will be highlighting a new format that will benefit both executives and the investors tuning in from all over the globe.

In September 2020, LD Micro. Inc. was acquired by SRAX, Inc., a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com.

Contact:

Name: Dennis P. Calvert, President and CEO of BioLargo

Phone: 888-400-2863

Address: 14921 Chestnut Street, Westminster CA, 92683

Email: dennis.calvert@biolargo.com

Source: BioLargo via LD Micro

Wednesday, 2 December 2020

BioLargo installs CupriDyne Clean air quality control systems for clients in 'break-out moment'

Source: Proactive Investors (https://ca.proactiveinvestors.com/companies/news/935546/biolargo-installs-cupridyne-clean-air-quality-control-systems-for-clients-in--break-out-moment--935546.html

 

BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive the group's subsidiary ONM Environmental Inc recently installed several large and financially significant CupriDyne Clean air quality control systems at public and private landfills.

Calvert says these projects will lead to breaking records in revenue numbers, and are noteworthy because of their size, sophistication, and scope relative to past projects. They feature CupriDyne Clean, the company's award-winning, cost-effective volatile organic compounds- (VOCs) control product that eliminates odor-causing compounds and VOCs rather than masking them.

Tuesday, 1 December 2020

BioLargo Winning Big Projects for CupriDyne Clean Delivery Systems

Subsidiary ONM Environmental leading the way

Westminster, CA – December 1, 2020 – ONM Environmental, Inc., a subsidiary of BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and a full-service environmental engineering company, has recently installed several large and financially significant CupriDyne Clean air quality control systems at public and private landfills. These projects are noteworthy because of their size, sophistication, and scope relative to past projects, and feature CupriDyne Clean, the company’s award-winning cost-effective odor and VOC control product that eliminates odor-causing compounds and VOCs rather than masking them.  

These most recent projects are driving increasing sales for ONM in recent months. Management anticipates these projects will propel the company to record revenues in the fourth quarter, assuming no delays in project execution occur as a result of significant new COVID-related government shutdowns or regulations.

These projects also include the use of ONM’s turnkey, self-contained misting trailers. These new trailers allow customers to control odors directly where new waste is being deposited on any given day. Designed and optimized to deliver ONM’s flagship product, CupriDyne Clean, these trailers lead to ongoing, continuous sales of this product, bolstering the overall scalability of the company’s air quality control business.

A video of the trailer can be viewed here: https://www.biolargo.com/cupridyne-misting-trailer

ONM also began working with two municipalities in Southern California, one of which required the installation of a 4,000-foot-long perimeter misting system for a landfill. The second involved ONM delivering multiple of its new portable misting trailers which use its flagship product CupriDyne Clean on an ongoing basis.

President of ONM Environmental, Joe Provenzano stated, “We have a reputation as a company that delivers the highest quality and most dependable air quality control solutions and deployment systems, even in some of the toughest on-the-ground conditions in industry. We are winning larger and more financially significant projects than ever before.”

The company provided a photo gallery from recent installations (including the new portable trailers). This photo gallery is available here: https://www.biolargo.com/case-studies

 

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard (www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

During the course of the stockholder presentation, BioLargo may make “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, regarding future events or the future financial performance of the company that are subject to change. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Tuesday, 17 November 2020

BioLargo's water technologies closer to commercialization, reports record 3Q

Source: Proactive Investors (https://ca.proactiveinvestors.com/companies/news/934217/biolargo-s-water-technologies-closer-to-commercialization-reports-record-3q-934217.html 



BioLargo, Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive its 3Q financial results saw its revenue rise 26% year-over-year to a record $0.67 million. Calvert says the group is ramping up several of its water technologies to prepare for commercialization including the AOS and the AEC, which he says will lead to first sales.

What's more, its industrial operating divisions each have a backlog of revenue-generating projects that collectively exceed $2 million, which it says will provide “reliable revenue” into 2021.

Monday, 16 November 2020

BioLargo Revenue Continues Breaking Records as Water Technologies Ready for Commercialization

Technology Portfolio Expanding

Westminster, CA – November 16, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, filed with the SEC its Quarterly Report on Form 10-Q for the period ended September 30, 2020 (www.biolargo.com/sec-filings).

BioLargo’s Third Quarter Accomplishments

  • Record revenue – generated record revenues in the third quarter, rebounding from early pandemic shutdowns
  • New business backlog – BioLargo’s industrial operating divisions each have a backlog of revenue-generating projects that collectively exceed $2 million, providing reliable revenue into 2021
  • Advanced PFAS (“forever chemicals”) removal technology – Refined the AEC water treatment technology, developed a modular AEC unit, and have entered into substantial negotiations with a major municipal water agency regarding a pilot project
  • New CupriDyne formula – developed a new CupriDyne formula and are preparing an application to register a product as a sanitizer and hard-surface disinfectant with the US EPA
  • Launched COVID product – our medical subsidiary launched Clyraguard Personal Protective Spray on Amazon, and expanded sales of Clyraguard from first quarter; it is launching a new product soon, with another expected in mid to late 2021
  • Developed a new technology – BioLargo engineers invented a way to extract valuable minerals from certain types of industrial waste, turning a customer’s liability into a billion-dollar revenue opportunity while also creating a long-term revenue opportunity for BioLargo’s engineering team
  • Sales of odor and VOC control solutions to Cannabis operators expanding – CupriDyne Clean odor control product’s use is expanding in the Cannabis industry
  • Municipal wastewater pilot under way – began construction of a commercial-scale AOS water treatment system for delivery to a municipal wastewater treatment plant in Montreal, Canada
  • Improved balance sheet – retired over $3.5 million in debt (by converting to equity), leaving approximately $1.1 million due in August of 2021 or later, and the remaining paid by Clyra subsidiary from sales or as funds are available from financing efforts

BioLargo President and CEO Dennis P. Calvert commented, “Several of our patented technologies are on the cusp of significant commercial breakout. Our two water technologies – the AOS and the AEC – are now ready for commercial trials that we believe will lead to first sales. We are constructing our first commercial ready AOS unit now. At the same time, we are refining comprehensive marketing plans for their rollout and are already in discussions with customers, distributors and strategic partners.”
















The company has continually advanced its robust portfolio of technologies since it started this journey in the spring of 2007. The technology portfolio has expanded to include:

  • PFAS removal
  • SARS-CoV-2 solutions
  • Infection control
  • Wound management
  • Regenerative tissue therapy
  • Disinfection
  • Air quality controls and systems including odor and VOC control
  • Water decontamination
  • Micro-pollutant destruction and removal
  • Legionella detection and water treatment solutions
  • Minerals processing

Calvert continued, “We have assembled world-class technologies and talent and are focused on their highest and best purpose. While extraordinarily difficult, we have consistently invested in R&D while advancing from technology to product and onto first commercial sales and bundled services. We are now witnessing the first stages of disruption, proving their opportunities for significant commercial futures. We believe the value of our technology portfolio is far greater than is currently reflected in our stock price and continue to march forward knowing that the portfolio has a future that will generate value for decades to come. The innovator’s journey is never easy, and there is no doubt that the pandemic presented real additional challenges for BioLargo, but we are now in a position where our balance sheet has dramatically improved, our revenues are rebounding, and we have several potentially disruptive technologies ready to launch into the marketplace. I was reminded recently by a highly trained and accomplished innovator that, ‘solutions to some of the most important challenges in the world LIVE at BioLargo’.  We agree and know it’s only a matter of time before we see their dramatic impact around the world for a greater good.”

 

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

During the course of the stockholder presentation, BioLargo may make “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, regarding future events or the future financial performance of the company that are subject to change. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

 

Monday, 2 November 2020

Clyraguard Highlighted in Rolling Stone and Men's Journal

BioLargo and its subsidiary Clyra Medical Technologies are rolling out Clyraguard around the country, and it's starting to turn some heads. Now that the product is available on the company's website and on Amazon, the timing is perfect.

Last week, two articles were published about Clyraguard that do a great job capturing the value of this product. First, a Rolling Stone article highlighted how Clyraguard can help improve mask-wearing practices to help keep people safe. Second, a Men's Journal article reviewed the product from a broader perspective.

You can get to these articles right here:

If you are a follower of BioLargo or Clyra, we'd love to hear your thoughts about the new product. Make sure to follow us on social media - you can find us at:

Tuesday, 27 October 2020

Odin (BioLargo/BKT Joint Venture) Headquarters Moving to Korea Water Cluster in Daegu, South Korea

Earlier this year, BioLargo announced the formation of a joint venture with BKT & Tomorrow Water to launch BioLargo’s patented odor and VOC control product CupriDyne Clean (www.cupridyne.com) into the Asian market under the brand name “Odin”. The new join venture was designed to manufacture and support distribution of the odor and VOC control products developed and sold by its subsidiary ONM Environmental, Inc. (www.onmenvironmental.com) in multiple countries throughout Asia, focusing initially on BKT’s established water and wastewater customer base.

BKT is a leading wastewater treatment solutions provider operating in the USA, South Korea, and Vietnam with a reputation for adopting innovative, environmentally sustainable technologies and practices. In the agreement between BioLargo and BKT, it was planned that the joint venture would eventually move its headquarters to the city of Daegu, which is a center for high-tech innovation in South Korea.

The BKT/BioLargo joint venture (Odin) is now officially moving its headquarters to the Korea Water Cluster in Daegu. The Korea Water Cluster is a newly opened water innovation hub in Daegu that provides significant business, scientific, engineering, human resources, and logistical assets to companies. Odin is set to be the first international joint venture headquartered at the Korea Water Cluster campus.

Water clusters and innovations groups exist all over the world, but the Korea Water Cluster is unique because of its significant physical footprint in Daegu, its substantial physical resources, and the funding it has received from the South Korean government. The Korea Water Cluster’s campus spans over 14 square kilometers, with state-of-the art testing facilities and business support centers.

Overview of Korea Water Cluster facilities (source: www.watercluster.or.kr


James Kim, COO of BKT, commented on the importance of the move to Daegu, “the Water Cluster will be a hub for R&D in the water  industry, and it will introduce innovative technologies in one place, providing opportunity for collaboration and cooperation among companies and ventures.”

He continued, “Korea Water Cluster will be a test bed and showcase for many innovative technologies not only for Korean clients but also many other clients in Asia. Odor is one of the major issues that wastewater treatment plants would like to remove, and it is becoming more important. By moving its headquarters to this Water Cluster, Odin will be naturally exposed to more clientele in Korea and also in Asia. BioLargo and Tomorrow Water signed an MOU with the City of Daegu at the WEFTEC last year, and the Mayor of Daegu promised strong support on market expansion in this region. Odin is the first foreign invested joint venture who moved into this cluster.”

Odin’s move to the Korea Water Cluster comes at a time when the joint venture is working to establish its manufacturing base for odor and VOC control products in South Korea. Not only will the move provide access for Odin to key opinion leaders in the water innovation industry in South Korea, but it will allow for significant business-to-business collaboration as the joint venture partners works to market Odin products in the region.

Wednesday, 21 October 2020

BioLargo Awarded Contract for Engineering Services at Major Chemical Manufacturing Facility

Westminster, CA – October 21, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, announced today that its subsidiary BioLargo Engineering, Science & Technologies (BLEST) has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer (RTO) systems used at a large chemical manufacturing plant on the East Coast of the US, owned by a global chemical company, that produces phenolic resins, antioxidants and related synthetic organic products. The contract is expected to execute with a series of milestones through mid-2021, with anticipated scope expanding the contract period to at least 24 months and over $500,000 in total revenue.

A Regenerative Thermal Oxidizer is a device that destroys unwanted organic air contaminants produced as a result of the phenolic resin production process. An RTO is a highly energy-efficient technology that uses waste heat to eliminate organic air contaminants, and is a crucial piece of equipment for this chemical plant.

The plant is preparing to shut down an existing, older RTO and re-route the exhaust treated by that RTO to a newer, much larger and more efficient RTO. This will result in significant energy efficiency and cost savings improvements to the facility. The work to reconfigure these RTO systems is not trivial, requiring substantial engineering and design work to ensure it proceeds safely and efficiently. BLEST has been contracted to conduct the initial engineering work to assess the feasibility of the RTO reconfiguration project. BLEST engineers have significant experience engineering and designing RTO systems, with some of its engineers having designed multiple RTO systems for the facility.

 

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863

Safe Harbor Act

During the course of the stockholder presentation, BioLargo may make “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, regarding future events or the future financial performance of the company that are subject to change. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Thursday, 15 October 2020

Lorianne Shultz Awarded 2020 NWRI-BioLargo Graduate Fellowship

For many years, BioLargo has sponsored fellowships offered by the National Water Research Institute (NWRI) to graduate students in the US who focus on cutting-edge water research. This $5,000 fellowship recognizes students who research the technical and scientific aspects of advanced water and wastewater treatment.

This year, we are happy to announce that the NWRI-BioLargo Graduate Fellowship has been awarded to Lorianne Shultz, a PhD student at the University of Central Florida. Shultz’s research project, which she is completing in the laboratory of Dr. Titel Jurca, is called “Chlorine Stable Heterogeneous Catalysts for the Remediation of Stubborn Water Pollutants”.

Lorianne Shultz, NWRI-
BioLargo Fellowship winner

Lorianne explained to us the importance of her research, “Pharmaceuticals and personal care products are accumulating in our waterways at alarming rates; this is especially true with the world’s growing population. This issue can be remediated through heterogenous catalytic degradation of these pollutants, a methodology that I believe is commonly overlooked in the water-industry. I was thrilled to receive this fellowship as it helps validate the use of catalytic materials for water-remediation and these funds help me expand this field of research further. I am excited to be working in connection with BioLargo, a company so dedicated to this field and at the forefront of improvement for water treatment systems.”

Dennis P. Calvert, President & CEO of BioLargo, commented, “Shultz’s research goals align well with NWRI’s mission to protect and improve water management in the US, and they also align with BioLargo’s vision of seeking innovative new methods of addressing tough contaminants that threaten the health and safety of people around the world. We are thrilled to sponsor her work, and we are excited to learn from her research.”

NWRI is a 501c3 nonprofit that collaborates with water utilities, regulators, and researchers in innovative ways to help develop new, healthy sources of drinking water. To learn more about NWRI’s graduate fellowship program, go to the NWRI website: https://www.nwri-usa.org/fellowships.

Wednesday, 14 October 2020

Clyraguard Personal Protection Spray Now Available On Amazon.Com For Consumers Nationwide

BioLargo subsidiary Clyra Medical Technologies Joins Forces with Powerplay Retail to Ensure

Broad Availability of Revolutionary Product to Safeguard Against Airborne Viruses

Westminster, CA – October 14, 2020 – Just in time for Amazon Prime Day, BioLargo, Inc. (OTCQB:BLGO), developer of sustainable life science technologies, today announced that Clyraguard, the personal disinfectant and germicidal spray that safely and easily decontaminates masks and face coverings, is now available at the Clyra Medical Store on Amazon.com. Clyraguard is manufactured by BioLargo’s subsidiary Clyra Medical Technologies, a med-tech company with deep experience fighting hospital-acquired infections with innovative technologies.

In addition, Clyra Medical announced a partnership with Powerplay Retail, an agency and distributor that has helped launch some of the best-known consumer products in the world, to roll-out Clyraguard to major retailers nationwide. Powerplay Retail brings to bear relationships with some of the world’s biggest online and in-store retailers, including more than 80 of the largest, most recognizable retailers in the United States.

BioLargo President & CEO Dennis Calvert commented, “We have assembled an exceptional team to execute a multi-phase roll out plan for Clyraguard. This Amazon launch, in partnership with Powerplay Retail, is another important step toward maximizing consumer access to this valuable product.”

“As we continue to battle this unprecedented pandemic, Clyraguard provides an embedded layer of iodine on one’s mask or face covering for additional protection against unwanted pathogens, including the SARS-CoV-2 virus, without having to remove your mask,” said Steve Harrison, CEO, Clyra Medical Technologies. “Until now, this hospital-grade disinfectant was available only to healthcare professionals. Making Clyraguard available on Amazon.com, as well as partnering with Powerplay Retail, ensures we can deliver a much-needed solution to consumers nationwide.”

Clyraguard has shown complete inactivation of SARS-CoV-2 (COVID-19), according to recent testing at University of Texas Medical Branch at Galveston, and is based on Clyra Medical’s original advanced wound care technology, which received 510(k) clearance from the Food and Drug Administration (FDA).  Clyraguard is a hospital-grade, FDA-registered disinfectant that is specifically indicated for PPE, like masks and face coverings.

“At Powerplay our goal is to help our retail partners find the right brands and the right technologies while weeding out the noise in this increasingly competitive marketspace,” said Tracy Thie, Principal, Co-Founder Powerplay Retail.  “As health and safety have become a core part of our daily lives, we have made it a point to help support our retail partners to bring the right health & wellness products to the masses. Our partnership with Clyra creates a great opportunity to bring Clyraguard to market at a time when people want and need this product.”

Clyraguard has been rigorously tested and proven to be safe and long-lasting, providing an extremely high 99.999% antimicrobial efficacy against viruses, bacteria and fungi.  Gentle and safe, its eco-friendly ingredients are mineral-based, alcohol-free, non-toxic, non-irritating and non-sensitizing.

Available in 4 oz. spray bottle, the personal protection spray is small enough for a purse or pocket yet contains two months of supply with typical usage, and for travelers, Clyraguard classifies under current TSA hand sanitizer exemptions. Clyraguard is now available to consumers online at www.clyramedical.com, the Clyra Medical Store on Amazon.com, and soon to be available at retailers nationwide.

 

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”.  We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About Clyra Medical Technologies

Clyra Medical Technologies, is a subsidiary of BioLargo, Inc. (OTCQB:BLGO), a sustainable science, technology and full-service environmental engineering company that makes life better by delivering world-class products and services across a broad range of industries, with a drive to deliver solutions in clean water and wastewater treatment, clean air and air quality control, and advanced antimicrobials for healthcare. 

About Powerplay Retail

Powerplay Retail is a privately held, Minnesota based company with offices in Bentonville, Arkansas, and Shenzhen China. With over 250 years of combined retail experience bringing brands like Beats by Dr. Dre and GoPro to consumers they continue to vet and identify new retail opportunities to best serve their brand and retail partners. For more information on Powerplay Retail, visit powerplayretail.com.

Contact

Dennis P. Calvert

President and CEO, BioLargo, Inc.

888-400-2863